TELL ME MORE
ABOUT THIS CLINICAL TRIAL for COVID-19 Antibody Therapy
This is an Open Label or Placebo Controlled Safety and Efficacy Study of an Investigational Medicine for COVID-19 in Adults.
Clinical Trial of an Antibody Cocktail for COVID-19
Study Location(s): Owensboro Kentucky, Evansville Indiana
Qualmedica Research is currently enrolling two clinical trials focused on a new antibody therapy developed by Eli Lilly. The BLAZE 1 study is for pediatric patients age 0 – 17 with underlying risk factors. The BLAZE 4 study is for patients 12 years and older with underlying risk factors. You may qualify if you have recenltly tested positive for COVID-19. If you are exhibiting symptoms of COVID-19, Qualmedica Research may administer a free rapid antigen test to see if you qualify for one of these studies.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimbursement up to $3000 may be available.